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Background: Although the burden of malaria has significantly declined in recent years in sub-Saharan Africa through the
widespread use of long-lasting insecticide treated bed-nets (LLINs) and artemisinin-based combination therapy, resurgence
of malaria is observed in some settings after several years of LLINs use. This study aimed to assess if LLINs use remains
protective against malaria during a period of resurgence of malaria morbidity in Dielmo, a rural village of Senegal.
Methods: In July 2008, LLINs were offered to all villagers and lately in July 2011, LLINs were renewed.
A longitudinal study was conducted between July, 2010 and December, 2011 among inhabitants of the village of
Dielmo to identify all episodes of fever. Thick smears stained with Giemsa were done for every febrile villager and
malaria attacks were treated with combination of Artesunate plus Amodiaquine. Cross-sectional surveys were also
conducted at the end of the rainy season (October 2010 and November 2011) to assess asymptomatic carriage. A
survey on LLINs use was done every quarter of the year. A random-effect logistic regression was used to assess the
effect of LLINs use on the risk of having a malaria attack after adjusting for the main risk factors.
Results: The study population included 449 individuals corresponding to a total of 2140 observations. One
hundred and fifteen (115) clinical malaria attacks attributed to P. falciparum (cases) have been recorded over the
study period. Most of the malaria cases occurred in October-December 2010 (49/115 i.e. 43%) and among adults
aged 15 years and over (50/115, i.e. 43%). During the study period, the use of LLINs was 61% among non-malaria
cases and only 42% among malaria clinical cases but differenced according to age group.
After adjusting on gender, age, rainfall and LLINs replacement, we found that LLINs use (AOR [95%CI] = 0.40 [0.25;
0.62], p < 0.001) remained a protective factor against malaria attacks during the study period.
Conclusion: LLINs use remains effective to reduce malaria burden. These results highlight the need to pursue
LLINs implementation in the current context of malaria elimination and to provide positive incentives to increase
its use in the population.
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A subsequent decline of malaria morbidity and mortality
has been achieved in recent years in sub-Saharan Africa
through the widespread use of artemisinin-based com-
bination therapy (ACT) and long-lasting insecticide-
treated nets (LLINs) [1-4]. Between 2000 and 2010,
nearly half of the countries affected by the disease were
able to reduce the number of malaria cases by more than
50% but the intensity of malaria decrease varies accord-
ing to the endemic status of the area [5].
With 207 million cases and 62,700 deaths related to
malaria in the world in 2012, this disease remains a
major public health concern. While the strong decline
of malaria burden has encouraged the goal of pre-
elimination and elimination of malaria [6,7], several con-
cerns about the future of malaria elimination efforts
are emerging. First, pyrethroid resistance of Anopheles
has been rapidly emerging [8,9]. Second, the impreg-
nated nets are known to act by reducing or removing
human-vector contact, which could lead to a decrease of
immunity in endemic areas among persons who were
previously immune [9]. Third, the protective effect of
LLINs use became debatable over the long term, espe-
cially in malaria endemic area. In Malawi, a recent study
showed that after five years of malaria prevalence de-
crease thanks to the intensification of control measures,
the downward trend is no longer significant [10]. Simi-
larly, a study conducted between 2002 and 2010 after
the introduction of LLINs in three sentinel sites in
Kenya showed that malaria prevalence significantly de-
creased between 2002 and 2006 but increased in two of
the three sites in 2010 [11].
In the rural village of Dielmo in Senegal, ACT and
LLINs have been implemented in June 2006 and July
2008 respectively [9]. LLINs introduction has been
followed-up by a sharp decrease of P. falciparum malaria
morbidity which was found to be 13-times lower be-
tween August 2008 and August 2010 than in the period
between January 2007 and July 2008 [9]. However, a
resurgence of malaria morbidity has been observed between
September and December 2010, i.e. 27–30 months after
the nets introduction [9]. A previous study published in
2011 suggested that Anopheles resistance to pyrethroid
could be a major factor in the increase of malaria morbid-
ity in 2010 [9]. However, it does not explore the role
played by LLINs use in the malaria upsurge period, espe-
cially whether its inhabitants had used it consistently over
the period and whether LLINs remained a protective fac-
tor against malaria attacks.
In this study, we aimed to document the evolution of
LLINs use over the long term and to assess its role
in malaria protection during the resurgence of malaria
clinical attacks using longitudinal data from the Dielmo
project.Methods
Setting: the Dielmo site
Since June 1990, a long-term research project is being
conducted among the population of Dielmo, a Senegalese
endemic malaria village, to understand the relationship
between malaria incidence, its transmission, and popula-
tion immunity against different Plasmodium species.
The Dielmo research site has been described in detail
elsewhere [12]. Briefly, the village is located in a Sudan-
savannah region of central Senegal at 280 km south-east
of Dakar on the marshy bank of the Nema, a small per-
manent stream where the persistence of anopheline
breeding sites is observed year-round. Malaria transmis-
sion is intense and perennial with respectively 89 and 76
infected bites per person per year in 2010 and 2011 [13].
The village comprises respectively a population of 468
and 485 inhabitants in 2010 and 2011 [13] living in 42
concessions with a median of 8 (2; 31) persons per
house. Most of the inhabitants are farmers. The serer
ethnic group represented 78% of the population while
13% and 9% of the villagers were respectively Mandingue
and miscellaneous [12].
Participants and procedures
All villagers of Dielmo willing to participate are involved
in a longitudinal follow-up including three main compo-
nents: i) daily home-based medical surveillance of all ep-
isodes of fever including treatment and prevention of
malaria attacks through ACT and LLINs; ii) repeat
cross-sectional surveys to document malaria prevalence;
iii) quarterly repeat cross-sectional surveys to document
LLIN use. Written informed consent was obtained from
all participants or from the guardians or the parents of
children enrolled. The study was approved by the Minis-
try of Health of Senegal, the assembled village popula-
tion and the National Ethics Committee of Senegal.
Home-based medical surveillance
All participating households were registered with key
socio-demographic information (household composition
and age, gender of its different members) and visited
daily. The presence or the absence in the village of each
enrolled household members was monitored and loca-
tion of absent member was reported. This enables the
identification of a resident member (defined by spending
at least 75% of time during the trimester in Dielmo) and
to compute the number of followed up person-days
under observation for each period. Body temperature
was systematically recorded at home three times a week
in children younger than 5 years, and in older children
and adults in cases of suspected fever or fever-related
symptoms. In case of fever, patients were referred to the
project health centre which was open 24 h a day, 7 days
a week and examined by a nurse. Thick smears stained
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site on thick smears was determined using light micros-
copy. The parasite leukocyte ratio was measured for
each plasmodial species. Episodes of fever were attribut-
able to P. falciparum malaria clinical attacks when para-
site density was higher than an age-dependent threshold
[14]. The threshold for P. falciparum attacks was ranged
from a maximum of 125 trophozoites per 100 leucocytes
in children aged 2 years to a minimum of 6 trophozoites
per 100 leucocytes in adults aged 60 years and over [14].
Malaria clinical attacks were treated with combination
Artesunate plus Amodiaquine by June 2006 until now.
The efficacy of the treatment was monitored by daily
clinical surveillance of patients and with at least one
control of parasitaemia between day 7 and day 35 after
fever resolved. In addition, the type of hemoglobin, the
ABO and rhesus blood group were systematically per-
formed for all enrolled individuals at the inclusion in the
project and consigned in a biological data bank [12].
Cross-sectional surveys
To assess asymptomatic carriage and malaria prevalence,
cross-sectional surveys were conducted at the end of the
rainy season (in October 2010 and November 2011)
when mosquitoes were abundant and when the trans-
mission was very high. All individuals enrolled in the
Dielmo project that were present in the village at the
time of the survey were eligible to participate.
Quarterly LLINs repeat cross-sectional surveys
LLINs (Permanet 2.0) were introduced for the first time
in the village in July 2008, where they have been offered
to all villagers. Three years after, in July 2011, all LLINs
were renewed. Simultaneously to the introduction of
LLINs, repeat home-based surveys have been carried out
to assess their use. Each participating household was vis-
ited quarterly in the morning by two technicians in
charge of recording whether the nets were hung above
the bed the night before and of administrating to house-
hold members a short questionnaire about LLINs use.
Individuals were asked if they had used nets the night
preceding the visit and whether they never, always or
sometimes used nets.
All collected data were entered into the 4D software
version 2004.5.
Study population
In our study, we focused on clinical observations cover-
ing the period from July 2010 to December 2011 where
rebound of malaria incidence has been observed. All in-
habitants of Dielmo who were enrolled in the project
during this period and for whom data on LLINs use
were available (i.e. participants who were investigated for
LLINs use) were included in the study. Exclusion criteriaincluded pregnant women which represent a group with
specific malaria risk factors.
Outcome definition
Malaria clinical attacks occurring among our study
population were gathered together in 6 quarters includ-
ing July-September 2010 (period 1); October-December
2010 (period 2); January-March 2011 (period 3); April-
June 2011 (period 4); July-September 2011 (period 5)
and October-December 2011 (period 6). Our analysis
was thus based on person-trimester observations. Mal-
aria cases were defined during the quarter as individuals
who had at least one malaria clinical attack. For each tri-
mester, we defined two groups according to the presence
or absence of malaria clinical attacks (malaria cases were
coded 1 and non- malaria cases were coded 0).
Statistical analysis
We calculated incidence rates of clinical malaria attacks
as the ratio of the number of clinical malaria attacks re-
corded during a given period divided by the number
followed up person-days under survey during the corre-
sponding period. We derived mean monthly incidences
rate by period from the daily incidence rates on the basis
of 30.4 days per month.
Factors associated with the outcome variable were in-
vestigated using a random-effect logistic regression
model, which took into account the interdependence of
successive observations for the same individuals (as we
used person-trimester observations) [15].
The following socio-demographic and biological vari-
ables were investigated in the analysis: sex, age group
(defined in 6 groups according to the literature [9,12]),
education (went to French school or not), being resident
during the quarter, type of hemoglobin, ABO group and
rhesus group. We also included in the analysis informa-
tion on rainfall defined by the cumulative number of
mm of rainfall during the previous quarter in order to
take into account the time gap between the occurrence
of rainfall and the recrudescence of malaria attacks.
Finally, information on LLINs included two variables:
LLINs use and LLINs replacement. LLINs use was intro-
duced using a dichotomous variable: “always use LLINs”
versus “not consistently use LLINs”; this second category
grouped together individuals who reported to “some-
times” or “never” use LLINs during the corresponding
quarter as well as individuals who do not have LLINs.
LLINs replacement was also defined as a dichotomous
variable indicating the time at which the nets have been
renewed (i.e. before and after July 2011).
First, univariate analyses were performed to identify sig-
nificant association. Factors with a P-value below 0.20 in
univariate analyses were considered eligible for the multi-
variate analysis. Second, a stepwise backwards-elimination
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the variables to keep in the final model. In addition, the
final model was adjusted for age groups to control for
demographic characteristics. The significance level was
fixed at p < 0.05 in the final model.
Analysis were performed using Stata Software version
11.0 (College Station, Texas, USA) and R software.
Results
Description of participants
We observed 2186 observations corresponding to 452
individuals during the study period. Among the 2186 ob-
servations, we excluded 3 observations among malaria
cases because they were not investigated for LLINs sur-
veys and another 43 which were related to pregnant
women. We finally obtained 2140 observations corre-
sponding to 449 individuals aged from one month to
100.7 years old with a mean of 23.4 years old and a pro-
portion of 49% of women. Among the 2140 observa-
tions, 115 (5.6%) were related to individuals who had at
least one malaria attack per trimester between July 2010
and December 2011 and 2025 observations were related
to individuals who had no malaria attacks. The profile of
the study population was shown in Figure 1.
Incidence of malaria clinical attacks over the study period
Two hundred and ninety seven (297) and 292 thick smears
were performed in October 2010 and November 2011 re-
spectively during cross-sectionnal surveys. P. falciparum
prevalence was 2.7% (8/297) in 2010 and 1.4% (4/292) in
2011. Table 1 describes the number of malaria clinical at-
tacks and monthly incidence by age-groups and by periods
while Figure 2 illustrates both the time trends of monthly2186 observations d
123 observations with at least 
one malaria attacks
3 were from persons who were  
not investigated for LLINs use 
5 were from pregnant women 
115 observations with at least one 
malaria attacks
2140 obser
Figure 1 Study observations profile.incidence (by age-groups and by periods) and of LLINs
use. Among the 115 malaria clinical cases, 10 to 16 cases
were recorded at each time period, except during the sec-
ond period (October-December 2010) where 49 of the
malaria clinical attacks were observed.
The incidence density of P. falciparum malaria attacks
was thus more than 3 fold higher in October-December
2010 with 4.92 attacks per 100 persons per month com-
pared with 1.05 in July-September 2010 (the lowest inci-
dence) and 1.58 in October-December 2011 (the second
highest incidence over the period). Over the whole study
period, the incidence density was also the highest among
the age groups 10–14 years old, 15–29 years and 5–9 years
with respectively 2.96, 2.81 and 2.47 attacks per 100 per-
sons per month versus 1.44, 1.28 and 0.96 in age groups <
5 years, 30–44 and >45 years, respectively. The three age
groups 10–14 years old, 15–29 years and 5–9 years were
also those with the highest incidence density during the
October-December 2010 period (incidence density = 6.63,
7.91 and 7.11 per 100 persons per month, respectively).
Description of LLINs use during the study period
Figure 3 shows the proportion of LLINs use according
to the presence or absence of malaria attacks and ac-
cording to the study period and Figure 4 illustrates the
proportion of LLINs use according to age groups and
the presence or absence of malaria attacks.
We observed that the use of LLINs was quite stable over
the study period with 197/360 (55%), 231/357 (65%), 191/
370 (52%), 181/364 (50%), 223/352 (63%) and 266/337
(79%) observations corresponding to individuals who al-
ways used LLINs at each of the different time periods.
The proportion of LLINs use was also systematically loweruring 6 quarters
2063 observations without 
malaria attacks
38 were from pregnant  
women
2025  no malaria attacks 
observations
vations analyzed 
Table 1 Number of follow-up days and Plasmodium falciparum morbidity by age group according to the periods of the
study
0-4 years 5-9 years 10-14 years 15-29 years 30-44 years > = 45 years Total
July-September 2010
Follow-up days 5218 4766 3897 5488 3553 5938 28860
Malaria attacks 3 3 2 1 0 1 10
Monthly incidence per 100 persons 1.748 1.914 1.560 0.554 0.000 0.512 1.053
October-December 2010
Follow-up days 5444 4701 4587 5384 4023 6113 30252
Malaria attacks 6 11 10 14 5 3 49
Monthly incidence per 100 persons 3.350 7.113 6.627 7.905 3.778 1.492 4.924
January-March 2011
Follow-up days 5475 5289 5206 4971 3902 5911 30754
Malaria attacks 2 1 4 1 1 3 12
Monthly incidence per 100 persons 1.111 0.575 2.336 0.612 0.779 1.543 1.186
April-June 2011
Follow-up days 5533 5695 4863 5319 4219 5689 31318
Malaria attacks 1 6 3 5 1 0 16
Monthly incidence per 100 persons 0.549 3.203 1.875 2.858 0.721 0.000 1.553
July-September 2011
Follow-up days 4972 5113 3281 5069 4088 5703 28226
Malaria attacks 3 1 1 4 3 1 13
Monthly incidence per 100 persons 1.834 0.595 0.927 2.399 2.231 0.533 1.400
October-December 2011
Follow-up days 4985 5257 3812 5174 3992 5642 28862
Malaria attacks 0 3 5 4 0 3 15
Monthly incidence per 100 persons 0 1.735 3.987 2.350 0 1.616 1.580
All the study period
Follow-up days 31627 30821 25646 31405 23777 34996 178272
Malaria attacks 15 25 25 29 10 11 115
Monthly incidence per 100 persons 1.442 2.466 2.963 2.807 1.279 0.956 1.961
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without malaria cases for each of the periods, except for
the last one (October-December 2011) where the propor-
tion of LLINs use was 93% (i.e. 14/15) among malaria
cases versus 78% (i.e. 252/322) among the group without
malaria cases.
Overall, the proportion of LLINs use was the highest
among children aged less than 5 years (268/367 i.e. 73%)
and the lowest among the 10–14 years and 15–29 years
age group (152/304 i.e. 50% and 194/432 i.e. 45% re-
spectively) (Figure 4). For all age groups, the proportion
of LLINs use was lower than 50% in malaria cases except
in children less than 5 years for whom the proportion of
nets used was about 60% (9/15) in malaria cases. In
addition, we observed that for all age groups the propor-
tion of LLINs use was systematically lower among
the group of malaria cases except in the 15–29 years
age groups where the proportion of LLINs use wasapproximately similar in the two groups (12/29 i.e. 41%
in the malaria group versus 182/403 i.e. 45% in the non-
malaria group).
Factors associated with the risk of having malaria
clinical attacks
Tables 2 and 3 respectively describe individual character-
istics for both the whole study population and according
to the two groups previously defined (i.e. observations
with malaria attacks and observations without malaria
attacks) and results of univariate and multivariate ana-
lysis of the risk of having malaria attacks. We observed
that the proportion of women was lower in the group
with malaria attacks than in the group without malaria
(43/115 i.e. 37% versus 1,013/2,025 i.e. 50%). With an
OR [95% CI] of 0.59 [0.39; 0.90], female gender was
found to be a protective factor in univariate analysis. As
already shown with the results on incidence density, the
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Figure 2 Monthly incidence of Plasmodium falciparum by age group and use of LLINs according to the periods of study.
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29 were higher in the group with malaria than in the
group without malaria. In univariate analysis, however, the
age group 10–14 years was the only age group signifi-
cantly associated with a higher risk of malaria compared
with children aged less than 5 years (OR [95%CI] =2.07
[1.03; 4.17]). Almost all cases (100/115 i.e. 87%) were
found in resident individuals but the proportion of resi-
dent in the group without malaria attacks was similar
(1787/2025 (88%)) and being resident was not found to be
associated with the risk of malaria in univariate analysis
(OR [95%CI] =0.89 [0.49; 1.59]). Biological characteristics
were also quite similar in the two groups and none0%
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%
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Figure 3 % of LLINs use according to the absence or presence of malariasignificant association was found in univariate analysis.
The type of hemoglobin AA was the most represented
with 1572/2140 (73.5%) observations in the whole study
population while only 143/2140 (6.7%) observations were
from the AS type and 11/2140 (0.5%) from the AC type.
The A and O blood groups represented respectively 550/
2140 (25.7%) and 743/2140 (34.7%) of the whole study
population. Finally, the proportion of observations re-
corded in individuals who always used LLINs (1241/2025
i.e. 61.3%) was higher in the group without malaria than
in the group with malaria (48/115 i.e. 41.7%). In univariate
analysis, the use of LLINs was found to be a protective
factor of malaria clinical attacks during the study period11 Apr.-Jun. 2011 Jul.-Sep. 2011 Oct.-Dec. 2011
 of study period
No malaria cases
at the different time periods.
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Figure 4 % of LLINs use by age groups according to the absence or presence of malaria.
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placement of LLINs in July 2011 tend to be a protective
factor of the risk of having malaria attacks, the association
was not significant at the 5% threshold in univariate ana-
lysis (OR [95%CI] =0.65 [0.42; 1.02], p = 0.06). Finally,
rainfall was significantly associated with a higher risk of
malaria (OR [95%CI] =1.0017 [1.001; 1.002], p < 0.001).
Most of those results were confirmed in the final
multivariate model. After adjustment on age groups and
rainfall, female gender (AOR [95%CI] =0.63 [0.41; 0.98],
p = 0.039), replacement of LLINs (AOR [95%CI] =0.57
[0.35; 0.92], p = 0.021) and LLINs use (AOR [95% CI] =
0.40 [0.25; 0.62], p < 0.001) were independent protective
factors against the risk of malaria clinical attacks.
Discussion
Thanks to the intensification of malaria control mea-
sures over the ten last years, malaria declined in many
African countries [1-4,11]. In Dielmo, a rural village of
Senegal, a similar trend was observed after the implemen-
tation of LLINs and ACT as first line drug anti-malaria
[9]. However, 27–30 months after LLINs introduction,
malaria morbidity increased, especially in older children
and adults. A previous publication highlights that this up-
surge coincided with important pyrethroid resistance of An.
gambiae [9]. The aim of this study was to explore the spe-
cific role of LLINs use on malaria resurgence that occurred
in Dielmo in late 2010 and 2011. Our results showed that
the use of LLINS remains a protective factor against mal-
aria attacks despite the resurgence of malaria morbidity: in-
dividuals who had malaria were indeed less likely to use
consistently their nets compared to individuals who did not
have malaria. We also observed a relatively high level of
LLINs use which remains quite stable during the study
period (between 50% and 79%) but a lower use of nets in
old children aged 10–14 years and younger adults aged15–29 years compared with other age groups. Regarding
vectors, most of the bites were still after midnight [9] and
they did not become early biters during our study period.
As well as in Dielmo, resurgence of malaria burden has
been reported in some countries of sub-Saharan Africa
[11,16,17], especially in Kenya where the lack of proper net
use has been suspected to be one of the factors contributing
to malaria prevalence rebound [11]. However, this study is
one of the first to assess the relationships between the evo-
lution of both LLINs use and malaria burden.
Our study results highlight the highest incidence of mal-
aria among adolescents aged 10–14 years and young
adults aged 15–29 years. Indeed, about 47% of clinical at-
tacks occurred among these age groups during our study
period compared with 22% before net implementation in
2006 and 2007 (Data not shown). The lower use of LLINs
among these age groups could explain the highest inci-
dence we observed. This could also be explained by the
decrease of immunity against Plasmodium falciparum due
to the use of LLINs. Indeed, it has been shown that living
in endemic regions and being exposed continuously to
mosquito bites provided immunity against clinical malaria
which decreased when exposure to malaria is discontin-
ued [18]. As impregnated nets act by reducing or remov-
ing human-vector contact, the immunity can disappear or
decrease when LLINs are often used. Studies in Kenya
showed that the mean age of people with clinical attacks
increased steadily as exposure to mosquito declined [19].
In our study, male gender was at higher risk of malaria
than female. Male gender has been found as a risk factor of
malaria in some studies but the association remains incon-
sistent [20,21]. In Dielmo, males, especially teenagers, often
slept late and strolled around the village (personal observa-
tion). Therefore, they are more vulnerable to mosquito
bites than others because mosquitoes are both exophilic
and endophilic in Dielmo.
Table 2 Socio-demographic and biological characteristics among the whole population and according to the absence
or presence of malaria attacks (n = 2,140)
Characteristics Subcategory Number of persons
n = 449
Number of observations
n = 2,140 n(%)
Malaria cases
No n = 2025 n(%) Yes n = 115 n(%)
Socio-demographic characteristics
Sex
Male - 1084 (51) 1012(50) 72 (63)
Female - 1056 (49) 1013 (50) 43 (37)
Resident
Yes - 1887 (88) 1787 (88) 100 (87)
No - 253 (12) 238 (12) 15 (13)
French School
Yes 37 (8) 155 (7) 144 (7) 11 (10)
No 362 (81) 1764 (82) 1672 (83) 92 (80)
Age group
<5 years old - 367 (17) 352 (17) 15 (13)
5-9 years old - 353 (17) 328 (16) 25 (22)
10-14 years old - 304 (14) 279 (14) 25 (22)
15-29 years old - 432 (20) 403 (20) 29 (25)
30-44 years old - 282 (13) 272 (13) 10 (9)
45 years old and over - 402 (19) 391 (19) 11 (10)
Periods
Jul.-Sep. 2010 360 (17) 360 (17) 350 (17) 10 (9)
Oct.-Dec. 2010 357 (17) 357 (17) 308 (15) 49 (43)
Jan.-Mar. 2011 370 (17) 370 (17) 358 (18) 12 (10)
Apr.-Jun. 2011 364 (17) 364 (17) 348 (17) 16 (14)
Jul.-Sep. 2011 352 (17) 352 (17) 339 (17) 13 (11)
Oct.-Dec. 2011 337 (16) 337 (16) 322 (16) 15 (13)
Biological characteristics
ABO Group
A 116 (26) 550 (26) 514 (25) 36 (31)
B 78 (17) 354 (17) 331(16) 23 (20)
AB 16 (4) 80 (4) 77 (4) 3 (3)
O 148 (33) 743 (35) 703 (35) 40 (35)
HB type
AA 325 (72) 1572 (74) 1479 (73) 93 (81)
AS 30 (7) 143 (7) 8 (7) 8 (7)
AC 3 (1) 11 (1) 11 (1) 0 (0)
Rhesus group
+ 355 (75) 1617 (76) 1518 (75) 99 (86)
- 23 (5) 110 (5) 107 (5) 3 (3)
Nets use characteristics
LLINs Use
Always 1289 (60) 1241 (61) 48 (42)
Not always 767 (36) 707 (35) 60 (52)
LLINs replacement
Yes 689 (32) 661 (33) 28 (24)
No 1451 (68) 1364 (67) 87 (76)
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Table 3 Random-effect logistic regression models exploring factors associated with malaria clinical cases (n = 2,140)
Univariate analysis Multivariate analysis
Characteristics Subcategory OR (95% CI) P-value AOR (95% CI) P-value
Socio-demographic characteristics
Sex
Male (ref) 1 1
Female 0.59 (0.39-0.90) 0.014 0.63 (0.41-0.98) 0.039
Resident
No (ref) 1
Yes 0.89 (0.49-1.59) 0.689
French School No (ref)
Yes 1.40 (0.67-2.89) 0.371
Age group
< 5 years old (ref) 1
5-9 years old 1.78 (0.89-3.57) 0.103 1.77 (0.86-3.65) 0.123
10-14 years old 2.07 (1.03-4.17) 0.041 1.82 (0.87-3.81) 0.111
15-29 years old 1.70 (0.86-3.33) 0.124 1.16 (0.56-2.41) 0.693
30-44 years old 0.86 (0.37-2.02) 0.731 0.81 (0.33-2.00) 0.648
45 years old and over 0.65 (0.29-1.49) 0.310 0.59 (0.25-1.42) 0.238
Periods
Jul.-Sep. 2010 (ref) 1
Oct.-Dec. 2010 6.25 (3.03-12.87) <0.001
Jan.-Mar. 2011 1.18 (0.49-2.80) 0.715
Apr.-Jun. 2011 1.62 (0.71-3.68) 0.248
Jul.-Sep. 2011 1.35 (0.57-3.16) 0.494
Oct.-Dec. 2011 1.65 (0.72-3.80) 0.235
ABO Group
A (ref) 1
B 0.99 (0.56-1.76) 0.986
AB 0.54 (0.15-1.89) 0.336
O 0.81 (0.49-1.32) 0.390
HB type
AA (ref) 1
AS + AC 0.87 (0.40-1.90) 0.730
Rhesus group
+ (ref) 1
- 0.43 (0.13-1.42) 0.166
LLINs use characteristics
LLINs Use
Not always (ref) 1
Always 0.45 (0.30-0.68) <0.001 0.40 (0.25-0.62) <0.001
LLINs replacement
No (ref) 1
Yes 0.65 (0.42-1.02) 0.060 0.57 (0.35-0.92) 0.021
Rainfall
1.0017 (1.0011-1.0023) <0.001 1.0023 (1.0016-1.0029) <0.001
OR: Odds ratio; AOR: adjusted odds ratio.
Wotodjo et al. Parasites & Vectors  (2015) 8:267 Page 9 of 11
Wotodjo et al. Parasites & Vectors  (2015) 8:267 Page 10 of 11Among factors independently associated with a lower
risk of malaria attacks, we found that both consistent
LLINs use and replacement of LLINs in 2011 had a pro-
tective effect against malaria. These results suggest that
despite an increase in the frequency of pyrethroid resist-
ance in An. gambiae in Dielmo (7% in 2007 to 48% in
2010 [9]), nets remain effective against malaria as they
can ensure at least physical protection. Indeed, 2 meta-
analysis studies have shown that impregnated nets de-
creased malaria incidence of about 24% or 39% in areas
with stable malaria, compared to untreated nets and
50% compared with no nets [5,22]. In addition, it has
been demonstrated that 50% of the protection of LLINs
is due to physical aspect and 50% to the presence of
insecticide [5]. Another study in Benin showed that
sleeping under LLINs in an area of pyrethroid resistance
provided the same protection as sleeping under un-
treated nets, regardless of its physical condition [23].
Some studies showed no association between the in-
crease of pyrethroid resistance and resurgence of malaria
burden or no reduction of the LLINs protective effect in
the area of pyrethroid resistance [24,25]. According to
these observations and to our results, LLINs remains ef-
fective against malaria burden because of its physical
protection at least and remains one of the best tools to
control malaria burden despite the emergence of Anoph-
eles resistance to pyrethroid. In addition, a recent study
suggests that to be effective, the nets dissemination cam-
paign should include motivation for using nets [26]. The
next challenge will be the communication and awareness
campaign about LLINs role and about the danger to
neglect it over the long term especially in a context of
immunity decrease.
Our results also showed that malaria prevalence de-
creased since the implementation of LLINs, suggesting a
decrease in infected mosquitoes and mosquito biting [9].
This decrease is also due to the use of ACT in first line
treatment against clinical malaria as some artemisinin
derivatives were known to have an impact on P. falcip-
arum gametocytes [27-29]. To maintain the recent good
outcomes against malaria, it is thus important to ensure
safety and affordable anti-malaria treatment to all mal-
aria endemic countries and take into account the vulner-
ability of older children and adults against malaria.
This study has some limitations. First, we could not
confirm the possible presence of a decrease in the
immunity against P. falciparum as no information on
immunity was collected. However, a recent study men-
tioned an important decrease of seropositivity against
crude extracts of P. falciparum schizonts among Dielmo
population between 2000 and 2010 [30]. Second, we ob-
served a slightly higher proportion of LLINs use in the
group of malaria clinical cases compared with the non-
malaria cases group in the last period (October-December2011). The difference between the two groups was how-
ever not significant.
We had controlled education status and there is no as-
sociation between education and malaria risk. In Dielmo,
almost all villagers are farmers and nets were distributed
freely to all inhabitants, so the socio-economic status
could not reflect residual confounding. Even if the results
were adjusted on the main known factors, some con-
founders could be missed. We are convinced that these
missed minor factors would not greatly change the results.
Conclusion
This study showed that LLINs remain effective despite the
resurgence of malaria. This resurgence was associated by
the non-use of LLINs. Malaria morbidity in adults in this
period had doubled as all new infected individuals devel-
oped symptoms of malaria, probably due to the loss of im-
munity. Immunological tests were needed to confirm the
loss of immunity hypothesis, already highlighted by Fode
et al. [30]. Our finding however suggest that scaling up
nets among populations remains an important preventive
tool against malaria morbidity, and that awareness cam-
paign and monitoring of its use are crucial to avoid mal-
aria resurgence.
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